Also
- Share via
Allergan Inc. said a U.S. federal appeals court ruled in favor of the company in a patent infringement suit against Apotex Inc., a Canadian generic-drug maker. The ruling bars Apotex from obtaining Food and Drug Administration approval to market a generic version of Irvine-based Allergan’s eye drug Acular.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
